Navigation Links
Access Pharmaceuticals to Conduct Conference Call to Update Financial Community
Date:3/10/2008

DALLAS, March 10 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced today that its management team has scheduled a conference call for March 13, 2008 at 10:00 a.m. ET to update the financial community about the status of its clinical trial programs as well as its business opportunities.

Interested parties may participate in the call by dialing (877) 407-8293; callers outside the U.S. may participate by dialing (201) 689-8349 about 5-10 minutes prior to 10:00 a.m. ET. The conference call will also be available on replay starting at 12:00 noon ET on March 13, 2008, and ending on April 13, 2008. For the replay, U.S. participants please dial (877) 660-6853 (replay account # 294, replay conference #278416). The access number for the replay for callers outside the U.S. is (201) 612-7415 (replay account # 294, replay conference # 278416).

About Access:

Access Pharmaceuticals, Inc. is an emerging biopharmaceutical company that develops and commercializes propriety products for the treatment and supportive care of cancer patients. Access' products include ProLindac(TM), currently in Phase 2 clinical testing of patients with ovarian cancer, and MuGard(TM) for the management of patients with mucositis. The company also has other advanced drug delivery technologies including Cobalamin(TM) -- mediated targeted delivery and oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; Prodrax(R), a non-toxic prodrug which is activated in the hypoxic zones of solid tumors to kill cancer cells; Alchemix, a chemotherapeutic agent that combines multiple modes of action to overcome drug resistance. Access is also developing Phenylbutyrate ("PB"), an HDAC inhibitor and differentiating agent currently a Phase 2 clinical candidate. For additiona
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
2. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
3. Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
4. New Analysis from 14 Countries Identifies Drug Access Priorities to Achieve 2010 AIDS Treatment Target
5. Demand for Spanish-Language Cancer Web Materials Quadruples; Internet Resources and Access Remain Scarce
6. Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
7. Access Pharmaceuticals to Present Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
8. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
9. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
10. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
11. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... December 17 ,Agendia, a world leader in ... and Drug Administration (FDA) cleared its MammaPrint breast,cancer ... only FDA-cleared,breast cancer recurrence test available to patients ... has issued four clearances for MammaPrint, covering,all aspects ... "This FDA clearance, along with our recently ...
(Date:12/17/2009)... SAN DIEGO, Dec. 17 Suneva Medical, ... that it has signed a multi-million dollar line ... The line of credit facility will be ... only FDA-approved microsphere-enhanced collagen dermal filler on the ... Aesthetic Market growth objectives. ,, "Today Suneva Medical ...
(Date:12/17/2009)... 17 Instacare Corp. (OTC Bulletin Board: ... life-enhancing prescription drugs and diagnostics and at home ... leading developer and provider of e-health technologies and ... today that as part of the preparation of ... to add two new Directors and has rejected, ...
Breaking Medicine Technology:FDA Broadens Clearance for Agendia's MammaPrint(R) 2Suneva Medical Signs Multi-Million Dollar Line of Credit Agreement with Western Technology Investment 2Suneva Medical Signs Multi-Million Dollar Line of Credit Agreement with Western Technology Investment 3Instacare Corp. Board of Directors Sets Growth Plans for 2010 2Normal cells far from cancer give nanosignals of trouble 9146 1Normal cells far from cancer give nanosignals of trouble 9146 2Normal cells far from cancer give nanosignals of trouble 9146 3Playing it safe 9143 1Claimsnet Announces Claims Processing Agreement With New Health Care Solutions Company 50956 1Claimsnet Announces Claims Processing Agreement With New Health Care Solutions Company 50956 2
(Date:12/17/2009)... help lengthen long bones in the arms and legs in order ... Because the device is completely internal, patients can remain mobile while ... , ... (PRWEB) December 17, 2009 -- ... at Park Meadows Cosmetic Surgery in Lone Tree, Colorado, ...
(Date:12/17/2009)... Dec. 17 Fred Hutchinson Cancer Research ... D.S.c., has been awarded the distinction of AAAS ... bestowed upon members of the American Association for ... peers. ,, Halloran is a researcher in the ... a professor of biostatistics at the University of ...
(Date:12/17/2009)... Blue Shield of Michigan announced today that Kevin Klobucar, ... current vice president for products and marketing, will succeed ... maintenance organization when Carlson retires at the end of ... Daniel J. Loepp, president and CEO of BCBSM, parent ... pending formal approval from the BCBSM and BCN boards ...
(Date:12/17/2009)... short-term effect may not be beneficial , , THURSDAY, Dec. ... researchers report that the immediate effect of the fish ... is a short-term increase in blood fats and the ... surprised to find that the acute response has some ... expect from chronic, long-term intake," said Lindsay E. Robinson, ...
(Date:12/17/2009)... to try alcohol, illegal drugs , , THURSDAY, Dec. 17 ... is riskier than using illicit drugs or binge drinking, ... increase the likelihood that they,ll experiment with alcohol or ... on the right track with cigarette smoking and need ... of other substances," Pamela S. Hyde, administrator of the ...
Breaking Medicine News(10 mins):Health News:Patent Granted on GenerOs EX, A Medical Device That Helps Bones Grow 2Health News:Patent Granted on GenerOs EX, A Medical Device That Helps Bones Grow 3Health News:M. Elizabeth Halloran Named AAAS Fellow 2Health News:M. Elizabeth Halloran Named AAAS Fellow 3Health News:M. Elizabeth Halloran Named AAAS Fellow 4Health News:Could Omega-3s Boost Blood Fat Levels? 2Health News:Teens Think Smoking More Dangerous Than Drinking, Drugs 2
... and Broader Kidney Care Community,in partnership with the Forum, ... Kidney Care Partners (KCP) - an ... manufacturers working together to improve quality of care for ... - today expressed alarm regarding the racial disparity among ...
... Underway, On-lineBALTIMORE, March 3 Maryland breast cancer patients ... angel on their sides: The Red Devils (TRD), ... quality of life for Maryland breast cancer patients and ... suburban D.C. area are Doctor,s Community Hospital, Holy ...
... Chester Santos Trains to Defend His TitleNORTHRIDGE, Calif., March ... 99 faces and names, two decks of shuffled playing ... a matter of minutes. Chester Santos, the 2008 USA ... challenges, among others, when he defends his title at ...
... Highland Good Steward Management ("HGSM") today announced it ... investment adviser, as a sub adviser to Highland ... HGSM focuses on incorporating environmental, social ... William "Doug" Douglass III, co-founder of K2, said, ...
... may significantly improve the safety of methadone, a drug ... heroin and other opioid drugs, according to researchers at ... the University of Washington in Seattle. , The researchers ... believed. Those incorrect assumptions about methadone have been making ...
... disease is a typical example of a malabsorption ... including folate and vitamin B12. Hyperhomocysteinemia is significantly ... disease than healthy controls. , A research team ... the effect of vitamin B6, folate, and vitamin ...
Other Medicine News:Health News:Kidney Care Partners Raises Alarm on Racial Disparities in Kidney Disease; Joins With National Minority Quality Forum to Educate Public, Congress During National Kidney Month 2Health News:Kidney Care Partners Raises Alarm on Racial Disparities in Kidney Disease; Joins With National Minority Quality Forum to Educate Public, Congress During National Kidney Month 3Health News:Red Devils Expand Into Suburban DC, Receive National Komen Grant 2Health News:The Making of a Memory Champion 2Health News:The Making of a Memory Champion 3Health News:K2 Advisors Named Investment Advisor by Highland Good Steward Management 2Health News:New information points to safer methadone use for treatment of pain and addiction 2Health News:New information points to safer methadone use for treatment of pain and addiction 3Health News:New information points to safer methadone use for treatment of pain and addiction 4Health News:Are vitamin supplements effective in celiac disease patients? 2
... immunoassay system built around the many positive ... important addition of Logic Driven Incubation (LDI). ... for optimal performance with the fastest possible ... such as the cardiac biomarkers and HCG ...
... For The Detection ... Uses Of C-Peptide Measurement:, ... fasting hypoglycemia , Assisting ... diabetes mellitus , Differentiating ...
... for the quantitative determination of C-peptide in ... Automatic Immunoassay System. C-peptide measurement is used ... patients treated with insulin, to distinguish between ... various other diagnostic applications in patients with ...
... Multifocal IOL was designed to provide a ... glasses in most situations. While distance vision ... to that of a single vision monofocal ... and about 19 in 20 people with ...
Medicine Products: